When was TechnoBioChem founded?

TechnoBioChem was founded in 2003.

Where is TechnoBioChem located?

TechnoBioChem is headquartered in Peristeri, Greece.

Where does TechnoBioChem rank among its competitors?

TechnoBioChem ranks 423rd amongst 422 active competitors, of which 42 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Abselion, which secured $8.41M in Oct, 2024.

Who are the top competitors of TechnoBioChem?

TechnoBioChem's top competitors include Siemens Healthineers, Illumina and Quanterix. Among them, Abselion secured the most recent funding round in October, 2024.

TechnoBioChem - 2026 Company Profile & Competitors

TechnoBioChem is an unfunded company based in Peristeri (Greece), founded in 2003. It operates as a Provider of biochemical reagents and scientific laboratory equipment for research. TechnoBioChem has not raised any funding yet. The company has 422 active competitors, including 42 funded and 56 that have exited. Its top competitors include companies like Siemens Healthineers, Illumina and Quanterix.

Company Details

Provider of biochemical reagents and scientific laboratory equipment for research. Business activities include the import and distribution of various laboratory consumables, analytical instrumentation, and glassware. Offerings support operations within academic laboratories, hospitals, pharmaceutical firms, and industrial research facilities. Materials provided are intended for use in research and development or quality control testing processes.

Key Metrics

Founded Year

2003

Location

Peristeri, Greece

Stage

Unfunded

Ranked

423^rd among 471 competitors

Similar Companies

Siemens Healthineers & 469 more

View TechnoBioChem's full profile

TechnoBioChem has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of TechnoBioChem include Siemens Healthineers, Illumina and Quanterix. Here is the list of Top 10 competitors of TechnoBioChem, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Siemens Healthineers 2017, Forchheim (Germany), Public	Provider of medical imaging laboratory diagnostics and clinical digital solutions	-	Qatar Investment Authority, Skyviews Life Science ... & 3 others	75/100
2nd	Illumina 1993, San Diego (United States), Public	Developer of technologies for analysis of genetic variation and function	$28M	Chevron Technology Ventures, Dow Chemical Company ... & 32 others	71/100
3rd	Quanterix 2007, Cambridge (United States), Public	Developer of assay kits for ultra-sensitive biomarker detection	$99.5M	T. Rowe Price, Novalis LifeSciences & 15 others	71/100
4th	BioLife Solutions 1987, Bothell (United States), Acquired	Developer of cell and gene therapies with the integrity of a single cell	-	-	67/100
5th	Biocare Medical 1997, Concord (United States), Acquired	Manufacturer of primary antibodies and instruments for immunohistochemistry applications	$85M	Excellere Partners, GHO Capital Partners & 3 others	65/100
6th	MGI 2016, Shenzhen (China), Series B	Provider of gene sequencing instruments, reagents, equipment, and related products	$1B	Guotai Junan Securities, CoStone Capital ... & 13 others	63/100
7th	Abselion 2018, Cambridge (United Kingdom), Series A	Provider of a benchtop instrument for protien research	$12.6M	University of Cambridge, M Ventures & 14 others	59/100
8th	Applied BioCode 2008, Santa Fe Springs (United States), Public	Developer of assay testing kits and instruments for in vitro diagnostics, research, and other industrial applications	$20.3M	ID Ventures America, TPTF & 4 others	59/100
9th	Bio Rad 1952, Hercules (United States), Public	Portfolio of products and services for life science research and clinical diagnostic markets	-	Bellevue Healthcare Trust, SMB Capital Partners ... & 3 others	58/100
10th	Mapi Pharma 2008, Ness Ziona (Israel), Series B	Clinical stage pharmaceutical company developing extended release versions of generic drugs.	$60M	Shavit Capital, aMoon & 3 others	56/100
423rd	TechnoBioChem 2003, Peristeri (Greece), Unfunded	Provider of biochemical reagents and scientific laboratory equipment for research	-	-	16/100